<DOC>
	<DOCNO>NCT00598182</DOCNO>
	<brief_summary>The objective study investigate : 1. evolution ADHD symptom , remission rate ADHD , social school function , familial relationship ; 2. adherence CONCERTA , treatment modality , average treatment duration 3-year follow-up period ; 3. effect medication change neuropsychological functioning .</brief_summary>
	<brief_title>Adherence Long-term Effect OROS Methylphenidate ( CONCERTA ) : A Follow-up Study</brief_title>
	<detailed_description>Attention-deficit/hyperactivity disorder ( ADHD ) common impairing disease among child adolescent . Methylphenidate , stimulant , effective treating patient . OROS methylphenidate ( CONCERTA ) provide ADHD patient convenient safer treatment approach immediate-release methylphenidate ( IR-MPH ) . However , little information long-term effect adherence CONCERTA . At NTUH Taiwan , randomize clinical trial OROS MPH perform 3 year ago 64 subject include treat either IR MPH OROS MPH follow OROS MPH . Therefore , purpose study follow patient , explore adherence rate CONCERTA , symptoms evolution , outcomes among patient . Overview Study Design : There two stage study . All study procedure perform obtain informed consent . Stage I : Medical chart subject review obtain information CONCERTA adherence ( also include dosage , treatment duration , clinic visit , miss visit etc . ) , psychiatric co-morbidities , treatment approach subject receive previous study . Subjects visit ( Visit 1 ) information baseline characteristic reason discontinue CONCERTA ( applicable ) record . The assessment include parent teacher rating Conner 's Teacher Parent Rating scale ( CPRS-R : S , CTRS-R : S ) , SNAP-IV rating scale , SKAMP rating scale , investigator rating Kiddie-SADS-E , Clinical Global Impression Social Adjustment Inventory Children Adolescents ( SAICA ) ; neuropsychological assessment ( Conner 's Continuous Performance Test , CPT , Cambridge Neuropsychological Test Automated Batteries , CANTA B ) perform subject . Stage II : All subject enrol stage one follow next 6 month . Medication ADHD treatment may use subject base investigator ' clinical judgment . Subjects visit clinic week-24 ( Visit 2 ) . The assessment Visit 1 perform Visit 2 . In addition , adherence treatment , adverse event , overall satisfaction treatment , academic performance 6 month record .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Subjects participate randomized clinical trial CONCERTA NTUH . Subjects whose parents/caregivers complete questionnaire study assist finish assessment properly study ; Subjects whose parent ( ) guardian ( ) sign date informed consent subject participate study . No .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Attention Deficit Disorder Hyperactivity</keyword>
	<keyword>OROS methylphenidate</keyword>
</DOC>